Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

2000 • 5,760 citations

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

1997 • 5,442 citations

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus

2001 • 4,289 citations

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

2002 • 3,483 citations

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

1994 • 2,343 citations

C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events

2003 • 2,283 citations

C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men

1999 • 1,952 citations

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

2000 • 1,703 citations

Effect of Statin Therapy on C-Reactive Protein Levels

2001 • 1,627 citations

Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events

2001 • 1,537 citations

Production of C-reactive protein and risk of coronary events in stable and unstable angina

1997 • 1,515 citations

Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

1999 • 1,488 citations

Associations of elevated Interleukin-6 and C-Reactive protein levels with mortality in the elderly∗∗Access the “Journal Club” discussion of this paper at http:/www.elsevier.com/locate/ajmselect/

1999 • 1,467 citations

Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels

1998 • 1,398 citations

High-Sensitivity C-Reactive Protein

2001 • 1,398 citations

Novel Risk Factors for Systemic Atherosclerosis

2001 • 1,297 citations

Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease

2000 • 1,220 citations

Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study

1996 • 1,106 citations

C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction

1998 • 1,033 citations

Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus

2002 • 893 citations

Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the Elderly

1997 • 838 citations

C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy

1998 • 788 citations

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

2001 • 783 citations

Novel Clinical Markers of Vascular Wall Inflammation

2001 • 750 citations

C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study

2002 • 717 citations

Effect of Postmenopausal Hormones on Inflammation-Sensitive Proteins

1999 • 679 citations

Inflammatory Biomarkers, Hormone Replacement Therapy, and Incident Coronary Heart Disease

2002 • 677 citations

Evaluation of Four Automated High-Sensitivity C-Reactive Protein Methods: Implications for Clinical and Epidemiological Applications

2000 • 593 citations

Relationship Between Interleukin 6 and Mortality in Patients With Unstable Coronary Artery Disease

2001 • 551 citations

Prospective Study of C-Reactive Protein, Homocysteine, and Plasma Lipid Levels as Predictors of Sudden Cardiac Death

2002 • 527 citations

Hormone Replacement Therapy and Increased Plasma Concentration of C-Reactive Protein

1999 • 455 citations

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

2003 • 418 citations

Variability and Classification Accuracy of Serial High-Sensitivity C-Reactive Protein Measurements in Healthy Adults

2001 • 415 citations

Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women

2002 • 408 citations

Evaluation of Nine Automated High-Sensitivity C-Reactive Protein Methods: Implications for Clinical and Epidemiological Applications. Part 2

2001 • 389 citations

C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men

2000 • 367 citations

Inflammation and Long-Term Mortality After Non–ST Elevation Acute Coronary Syndrome Treated With a Very Early Invasive Strategy in 1042 Consecutive Patients

2002 • 243 citations

Abciximab Suppresses the Rise in Levels of Circulating Inflammatory Markers After Percutaneous Coronary Revascularization

2001 • 197 citations

C-reactive protein and myocardial infarction

2002 • 178 citations

Effect of Clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

2001 • 138 citations

Need to Test the Arterial Inflammation Hypothesis

2002 • 138 citations

Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease. Prospective analysis from the women’s health initiative observational study

2003 • 92 citations

Is C-Reactive Protein Specific for Vascular Disease in Women?

2002 • 80 citations

Projected life-expectancy gains with statin therapy for individuals with elevated c-reactive protein levels

2002 • 41 citations